Proteomics Facility News Today

With more than $3 million from the U.S. Department of Defense, one University of Notre Dame researcher is on a mission to help eliminate PFAS on militar...

Proteomic Specialist in Biological Sciences, Research Related with UNIVERSITY OF MELBOURNE. Apply Today.

Scientists at the University of Dundee and the University of Cambridge have discovered(1) how Cytotoxic T cells, - the white blood cells that recognise and eliminate threats, such as tumour cells and cells infected with invading viruses –are able to successfully reload the toxic weapons they use as they hunt down targets. Click to read more...

Director of the Moulder Center for Drug Discovery Research job in Philadelphia, Pennsylvania with Temple University School of Pharmacy. Apply Today.

Tenure-Track Faculty Position in the Department of Pharmaceutical Sciences job in Philadelphia, Pennsylvania with Temple University School of Pharmacy. Apply Today.

 E-Mail IMAGE: A preclinical study shows an antibody-drug conjugate (ADC) targeting surface protein MT1-MMP can act as a guided missile in eradicating osteosarcoma tumor cells without damaging normal tissues. This technology, using... view more  Credit: MD Anderson Cancer Center Abstract #LB008 HOUSTON -- A preclinical study led by researchers at The University of Texas MD Anderson Cancer Center shows an antibody-drug conjugate (ADC) targeting surface protein MT1-MMP can act as a guid...

Date Time Positive signs of immunity after COVID-19 infection Australian scientists have described the evolution of immunity levels up to four months following COVID-19 infection, finding that while antibody levels drop dramatically in the first one to two months, the decrease then slows down substantially. The findings suggest that protective COVID-19 vaccines should ideally generate stronger antibody responses than natural infection. The research, led by Professor Stephen Kent from the Dohert...